"Eventually traders will sell out & this stock will then have a...

"Eventually traders will sell out & this stock will then have a big run based on its fundamentals."

If we've learnt anything in the last few days it's that Australian investing is almost all chart based. Traders with the instincts of sharks, the attention spans of goldfish, who don't know/care if they're trading diamonds or dead babies, and who don't need fundamentals.

And anyway the fundamental fundamental is that management are too busy feeding themselves to develop a business plan that might see BTA become a blue chip stock. Instead of value adding our intellectual property, their idea of good management is to give over control to a partner who develops, produces and sells the drugs, and pays just enough royalty to fund management lifestyles.
Where's the ongoing research? What's the fifty year plan?


BTA has a cure for the common cold. The pharm. industry doesn't want it to succeed because of the money being made treating cold symptoms. A pharm. will only partner BTA to sabotage the cure.
Relenza royalties should be used by BTA to trial, manufacture, and market the cure independently. That's a plan.

Poorly performing management must be culled.